HEALTH

  • 563
  • 536

Targeting RAS to overcome FLT3 AML drug resistance - Drug Target Review

It was discovered that targeting RAS proteins prevent cancer cells from using different signalling pathways to escape cell death.

image

Ads

Video News

Hot News

Ads

News Letter

Your email address will not be this published. Required fields are News Today.